Aleafia Health Inc ALEAF

Healthcare Cannabis

Aleafia Health Inc. is a Canada-based cannabis company. The Company offers cannabis products in Canada and destined for international markets, including Australia and Germany. The Company operates a virtual medical cannabis clinic staffed by physicians and nurse practitioners, which provide health and wellness services across Canada. It owns three licensed cannabis production facilities and operates a located distribution center all in the province of Ontario, including an outdoor cannabis cultivation facility in Canada. The Company produces a diverse portfolio of cannabis and cannabis derivative products, including dried flower, pre-roll, milled, vapes, oils, capsules, edibles, sublingual strips, and topicals, for sale in Canada in the medical and adult-use markets, and in select international jurisdictions. Its subsidiaries include Aleafia Inc., Canabo Medical Corporation, Aleafia Farms Inc., Emblem Corp., Emblem Cannabis Corporation, GrowWise Health Limited and other.

GREY:ALEAF - Post by User

Aleafia Health Inc > CEO BENIC TO PRESENT AT VIRTUAL INVESTOR CONF SEP 9/11AM ET

<< Previous

Bullboard Posts

Next >>

Post by Humaniston Sep 07, 2021 3:41pm

281 Views

Post# 33819999

CEO BENIC TO PRESENT AT VIRTUAL INVESTOR CONF SEP 9/11AM ET

Aleafia Health CEO Geoffrey Benic to Present at Virtual Investor Conference
9/07/2021 8:35 AM ET • PR Newswire

Aleafia Health CEO Geoffrey Benic to Present at Virtual Investor Conference PR Newswire
TORONTO, Sept. 7, 2021 /PRNewswire/ -- Aleafia Health Inc. (TSX: AH) (OTCQX: ALEAF), a leader in cannabis wellness products and brands, today announced that CEO Geoffrey Benic will present in two virtual investor conferences on September 9, 2021, at 11:00 a.m. ET.

(PRNewsfoto/VirtualInvestorConferences.com)

OTC Markets Cannabis Investor Conference
DATE: September 9, 2021
TIME: 11:00 a.m. EDT
LINK: REGISTER
Q2 2021 Highlights
Selected highlights for the three months ended June 30, 2021:

Adult-use cannabis net revenue increased 87% compared to the prior quarter
Medical cannabis net revenue increased 23% compared to the prior quarter
13 additional product SKUs released across multiple product formats
For the first time, medical cannabis product was made available for sale in Germany
Commenced onboarding of medical cannabis patients through exclusive partnership with Unifor
Maintained strong adjusted gross margin on cannabis net revenue of 49%